Target intelligence / Profile preview

Intestinal microbial community structure restoration

Molecular classification
Other
01

Overview

"Intestinal microbial community structure restoration" refers to therapeutic approaches—such as dietary changes, probiotics, prebiotics, synbiotics, antibiotics (followed by restoration), and especially fecal microbiota transplant (FMT)—that aim to restore a healthy balance and diversity in the gut microbiota. This restoration is associated with improvements in conditions linked to dysbiosis, such as recurrent *Clostridioides difficile* infection, irritable bowel syndrome, metabolic diseases, inflammatory bowel diseases, and some autoimmune and malignancy risk. The target is not a molecule but rather the overall structure and composition of the microbial community within the gut. There is no unique molecular identifier, and the phrase should not be considered a molecular drug target.

Other names
Gut microbiota restorationRestoration of gut microbial communityGut microbiome modulationMicrobiome reconstitutionMicrobial community normalization
02

Mechanism of action

Restoration or augmentation of commensal microbial populations; Suppression of pathogenic or dysbiotic taxa; Enhancement of beneficial metabolite production (e.g. SCFAs); Improvement of host immune tolerance; Modulation of bile acid metabolism

03

Biological functions

Modulation of nutrient metabolismImmune system regulationMaintenance of intestinal barrier integrityCompetitive inhibition of pathogensRegulation of host inflammatory responseProduction of vitamins and metabolites (e.g. short-chain fatty acids, SCFAs)
04

Disease associations

Gastrointestinal infection (e.g. *Clostridioides difficile*)Inflammatory bowel diseaseIrritable bowel syndromeMetabolic syndromeCancer (e.g. colorectal cancer)Autoimmune and chronic inflammatory diseases
05

Safety considerations

Lack of specificity/standardization in defining a "healthy" microbiomeRisk of transferring pathogens with FMTAdverse immune or metabolic reactions to microbiome interventionsAntibiotic resistanceLong-term impacts on host metabolism and immunity are still incompletely understood
06

Interacting drugs

Probiotics

6 more in the full profile.

07

Biomarkers

Microbial taxonomic diversity (alpha/beta diversity markers)SCFA levels in stoolButyrate/propionate/acetate concentrationsInflammatory biomarkers (e.g. interleukin 6)Fecal bile acidsFecal calprotectin

Beyond the preview

Go deeper on Intestinal microbial community structure restoration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal microbial community structure restoration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call